Unibest
← Back to patent-cliff list

Tiagabine Hydrochloride

Tier C — Watch / trade

Tiagabine Hydrochloride

Abbott Laboratories
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:GAT1

Brand:Tiabex, Gabitril

Indications (approved):Epilepsy, Seizure

Regional status

US
Approved
1997-09-30
EU
Approved
1996-01-01
China
Phase III
2014-04-02
Japan
-

Synthetic routes & intermediates4 routes

Originator routes × 1Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield 5.60 g
TIAG-0015834-16-2TIAG-00214282-76-9TIAG-003148319-25-9TIAG-00430717-55-6TIAG-0054333-56-6TIAG-006148319-26-0TIAG-007109857-81-0TIAG-00825137-01-3TIAG-009145821-58-5TIAG-0102969-81-5API · Tiagabine Hydrochloride
CodeCAS No.Intermediate
TIAG-0015834-16-23-methylthiophene-2-carbaldehyde
TIAG-00214282-76-92-bromo-3-methylthiophene
TIAG-003148319-25-9bis(3-methylthiophen-2-yl)methanol
TIAG-00430717-55-6bis(3-methylthiophen-2-yl)methanone
TIAG-0054333-56-6bromocyclopropane
TIAG-006148319-26-0cyclopropylbis(3-methylthiophen-2-yl)methanol
TIAG-007109857-81-02,2'-(4-bromobut-1-ene-1,1-diyl)bis(3-methylthiophene)
TIAG-00825137-01-3ethyl (R)-piperidine-3-carboxylate
TIAG-009145821-58-5ethyl (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylate
TIAG-0102969-81-5ethyl 4-bromobutanoate
OptimisedRoute 2Steps 7 · Total yield 28.00 g
TIAG-01153374-61-1TIAG-012—TIAG-013157925-13-8TIAG-014157925-14-9TIAG-015157925-15-0TIAG-016157925-16-1TIAG-017157925-17-2TIAG-0015834-16-2TIAG-0054333-56-6TIAG-00825137-01-3API · Tiagabine Hydrochloride
CodeCAS No.Intermediate
TIAG-01153374-61-12-bromo-5-chloro-3-methylthiophene
TIAG-012-(5-chloro-3-methylthiophen-2-yl)(3-methylthiophen-2-yl)methanol
TIAG-013157925-13-8(5-chloro-3-methylthiophen-2-yl)(3-methylthiophen-2-yl)methanone
TIAG-014157925-14-9(5-methoxy-3-methylthiophen-2-yl)(3-methylthiophen-2-yl)methanone
TIAG-015157925-15-0cyclopropyl(5-methoxy-3-methylthiophen-2-yl)(3-methylthiophen-2-yl)methanol
TIAG-016157925-16-1(Z)-5-(4-bromo-1-(3-methylthiophen-2-yl)butylidene)-4-methylthiophen-2(5H)-one
TIAG-017157925-17-2ethyl (R,Z)-1-(4-(3-methyl-5-oxothiophen-2(5H)-ylidene)-4-(3-methylthiophen-2-yl)butyl)piperidine-3-carboxylate
TIAG-0015834-16-23-methylthiophene-2-carbaldehyde
TIAG-0054333-56-6bromocyclopropane
TIAG-00825137-01-3ethyl (R)-piperidine-3-carboxylate
OptimisedRoute 3Steps 6 · Total yield 93.00 g
TIAG-00214282-76-9TIAG-01896-48-0TIAG-019847233-26-5TIAG-020847233-13-0TIAG-021495-19-2TIAG-0221499189-55-7TIAG-023148319-38-4TIAG-024—API · Tiagabine Hydrochloride
CodeCAS No.Intermediate
TIAG-00214282-76-92-bromo-3-methylthiophene
TIAG-01896-48-0dihydrofuran-2(3H)-one
TIAG-019847233-26-51,1-bis(3-methylthiophen-2-yl)butane-1,4-diol
TIAG-020847233-13-04,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl methanesulfonate
TIAG-021495-19-2methyl 1,2,5,6-tetrahydropyridine-3-carboxylate
TIAG-0221499189-55-7methyl 1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)-1,2,5,6-tetrahydropyridine-3-carboxylate
TIAG-023148319-38-41-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid
TIAG-024--
OptimisedRoute 4Steps 6 · Total yield 39.00 g
TIAG-00430717-55-6TIAG-00825137-01-3TIAG-009145821-58-5TIAG-02542843-94-7TIAG-0261417220-54-2TIAG-0271417220-55-3TIAG-0281417220-56-4TIAG-0291417220-57-5API · Tiagabine Hydrochloride
CodeCAS No.Intermediate
TIAG-00430717-55-6bis(3-methylthiophen-2-yl)methanone
TIAG-00825137-01-3ethyl (R)-piperidine-3-carboxylate
TIAG-009145821-58-5ethyl (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylate
TIAG-02542843-94-7ethyl 3-(bromotriphenyl-l5-phosphanyl)propanoate
TIAG-0261417220-54-2ethyl 4,4-bis(3-methylthiophen-2-yl)but-3-enoate
TIAG-0271417220-55-34,4-bis(3-methylthiophen-2-yl)but-3-enoic acid
TIAG-0281417220-56-44,4-bis(3-methylthiophen-2-yl)but-3-enoyl chloride
TIAG-0291417220-57-5ethyl (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enoyl)piperidine-3-carboxylate

Frequently asked questions

What are the approved indications of Tiagabine Hydrochloride?

Approved indications include: Epilepsy, Seizure.

When does the Tiagabine Hydrochloride patent expire?

No public expiry year is available for Tiagabine Hydrochloride yet; this page updates once verified.

How many synthesis routes are recorded for Tiagabine Hydrochloride?

4 synthesis routes are recorded; the shortest is 6 steps with 93.00 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Tiagabine Hydrochloride intermediates?

All intermediates in Tiagabine Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Tiagabine Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-04